NurExone Biologic (OTCQBNRXBF) (TSXV NRX) (FSE J90) Revenue and Competitors
Estimated Revenue & Valuation
- NurExone Biologic (OTCQBNRXBF) (TSXV NRX) (FSE J90)'s estimated annual revenue is currently $5.3M per year.
- NurExone Biologic (OTCQBNRXBF) (TSXV NRX) (FSE J90)'s estimated revenue per employee is $188,214
Employee Data
- NurExone Biologic (OTCQBNRXBF) (TSXV NRX) (FSE J90) has 28 Employees.
- NurExone Biologic (OTCQBNRXBF) (TSXV NRX) (FSE J90) grew their employee count by 56% last year.
NurExone Biologic (OTCQBNRXBF) (TSXV NRX) (FSE J90)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Director | Reveal Email/Phone |
2 | Co-Founder, Business Development Manager | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Head Bioprocess Development | Reveal Email/Phone |
5 | Head CMC ,Quality and Regulatory | Reveal Email/Phone |
6 | Head Preclinical Studies | Reveal Email/Phone |
7 | Head Scientific Collaboration and External Partnerships | Reveal Email/Phone |
8 | Head Scientific Collaborations & External Partnerships | Reveal Email/Phone |
9 | R&D Director | Reveal Email/Phone |
10 | Director R&D | Reveal Email/Phone |
NurExone Biologic (OTCQBNRXBF) (TSXV NRX) (FSE J90) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.8M | 18 | -10% | $43M | N/A |
#2 | $0.8M | 5 | 0% | N/A | N/A |
#3 | $6M | 39 | 5% | $23.4M | N/A |
#4 | $8.1M | 52 | 27% | $12.5M | N/A |
#5 | $1.6M | 10 | 0% | N/A | N/A |
#6 | $3.6M | 23 | 5% | $8.44M | N/A |
#7 | $5.3M | 34 | 0% | N/A | N/A |
#8 | $2.8M | 18 | 38% | $6.1M | N/A |
#9 | $9.3M | 60 | 40% | $22M | N/A |
#10 | $5.3M | 28 | 56% | N/A | N/A |
What Is NurExone Biologic (OTCQBNRXBF) (TSXV NRX) (FSE J90)?
NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System.\nThe breakthrough exosome-based technology was proven in preclinical studies to have the potential to treat spinal cord injuries.
keywords:N/A
N/A
Total Funding
28
Number of Employees
$5.3M
Revenue (est)
56%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Haifa
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.1M | 29 | -19% | N/A |
#2 | $3.6M | 31 | -9% | N/A |
#3 | $3.3M | 32 | 0% | N/A |
#4 | $8.8M | 37 | 32% | N/A |
#5 | $5.2M | 41 | 14% | N/A |